Akèy › Kondisyon Post-COVID (Long COVID) › Illinois › Chicago
Etid klinik pou Kondisyon Post-COVID (Long COVID) nan Chicago, IL
11 etid pou Kondisyon Post-COVID (Long COVID) ap chèche patisipan nan sit nan ak bò kote Chicago (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
Ap rekriteFaz 3
- Rush University Medical Center ( Site 3748), Chicago
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Ap rekriteFaz 3
- Northwestern Memorial Hospital, Chicago
- Northwestern University Feinberg School of Medicine, Chicago
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
Ap rekriteFaz 3
- Illinois Research Network (ILLInet), University of Illinois Chicago, Chicago
Dime La VerDAD: Verify, Debunk, and Disseminate
Ap rekriteVolontè an sante akeyi
- University of Chicago, Chicago
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
Ap rekriteFaz 3
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Cognitive-Sensorimotor Function in Long-COVID
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Jesse Brown VA Medical Center, Chicago, IL, Chicago
Dysbiosis & Long COVID
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- The University of Chicago, Chicago
A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection
Ap rekriteFaz 4Volontè an sante akeyi
- University of Chicago, Chicago
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
Ap rekriteFaz 3
- University of Chicago Medical Center, Chicago
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Ap rekriteFaz 3
- University of Illinois Health, Chicago
Convalescent Plasma as a Possible Treatment for COVID-19
Ap rekriteFaz 2
- University of Illinois at Chicago, Chicago
Etid Kondisyon Post-COVID (Long COVID) nan lòt vil
- New York City, NY15 etid
- Houston, TX13 etid
- Boston, MA13 etid
- Baltimore, MD12 etid
- Washington, DC10 etid
- San Francisco, CA8 etid
- Durham, NC8 etid
- Atlanta, GA8 etid
- San Diego, CA7 etid
- Los Angeles, CA6 etid
- Pittsburgh, PA6 etid
- Miami, FL6 etid
Lòt etid nan Chicago
- Kansè Poumon ki pa ti selil61 etid
- Kansè nan tete59 etid
- Kansè (tout kalite)51 etid
- Kansè Metastatik45 etid
- Kansè pwostat45 etid
- Kansè poumon41 etid
- Obèsite41 etid
- Kansè ovè36 etid
- Kansè kolorektal34 etid
- Akidan serebavaskilè34 etid
- Ensifizyans kadyak31 etid
- Sipwa29 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.